Key result
The Framingham model defined only 5% of the asymptomatic high-risk Indian cohort to be at high risk for CVD, suggesting an underestimation in this genetically predisposed population.
Why the study?
Do British, European, and Framingham predictive CVD risk scores accurately stratify cardiovascular risk in an asymptomatic high-risk Indian population?
Cross-Sectional
Do British, European, and Framingham predictive CVD risk scores accurately stratify cardiovascular risk in an asymptomatic high-risk Indian population?
Standard Western cardiovascular risk prediction models like Framingham may significantly underestimate risk in Asian Indians, highlighting the need for population-specific risk scores incorporating novel biomarkers.
Answers are grounded in this paper and cite their sources.
May underestimate CVD risk in high-risk Indians; leaves open validation of ethnicity-specific scores in prospective studies.
The increasing pressure on health resources has led to the emergence of risk assessment as an essential tool in the management of cardiovascular disease (CVD). Concern exists regarding the validity of their generalization to all populations. Existing risk scoring models do not incorporate emerging ‘novel’ risk factors. In this context, the aim of the study was to examine the relevance of British, European, and Framingham predictive CVD risk scores to the asymptomatic high risk Indian population. Blood samples drawn from the participants were analyzed for various ‘traditional’ and ‘novel’ biomarkers, and their CVD risk factor profiling was also done. The Framingham model defined only 5% of the study cohort to be at high risk, which appears to be an underestimation of CVD risk in this genetically predisposed population. These subjects at high risk had significantly elevated levels of lipid, pro-inflammatory, pro-thrombotic, and serological markers. It is more relevant to develop risk predictive scores for application to the Indian population. This study substantiates the argument that alternative approaches to risk stratification are required in order to make them more adaptable and applicable to different populations with varying risk factor and disease patterns.
No takes yet. Share an insight, caveat, or question.
Veena Rao (2008) conducted a cross-sectional in Cardiovascular disease risk. Cardiovascular disease risk prediction models (British, European, and Framingham) was evaluated on Proportion of cohort defined as high risk by the Framingham model. The Framingham model defined only 5% of the asymptomatic high-risk Indian cohort to be at high risk for CVD, suggesting an underestimation in this genetically predisposed population.
Synapse has enriched 10 related papers. Consider them for comparative context: